The Use of FGF21 Analogues in MASH and MASH Cirrhosis – Metabolic Master Regulators or Liver-Specific Mechanisms? ☆

JHEP Reports · Published 2026-07-01 · DOI 10.1016/j.jhepr.2026.101957

Free full text

Authors (2)

A.G. Holleboom, Jörn M. Schattenberg

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Holleboom, A., Schattenberg, J. (2026). The Use of FGF21 Analogues in MASH and MASH Cirrhosis – Metabolic Master Regulators or Liver-Specific Mechanisms? ☆. JHEP Reports. https://doi.org/10.1016/j.jhepr.2026.101957

Related articles